Analytical Data
-
Gene name
FAM135B
- Application
-
Alternative Names
C8ORFK32
-
Species
Mouse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9DAI6
-
Expression Region
Leu1068~Lys1403
-
Molecular Weight
42kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM135B, a member of the FAM135 gene family, has garnered attention in recent years due to its potential roles in various cellular processes and diseases. Originally identified through genomic studies, FAM135B is believed to participate in pathways that regulate cell proliferation, apoptosis, and immune response. Research indicates that alterations in the expression of FAM135B may be implicated in several types of cancer, making it a candidate for exploration in tumor biology and therapeutic interventions. As a recombinant protein, FAM135B can be effectively expressed and purified for in vitro studies, allowing researchers to delve deeper into its biological functions and interaction networks. Understanding the molecular mechanisms governed by FAM135B is crucial for elucidating its role in health and disease. Additionally, studying the protein’s structure and function may unveil new insights into its potential as a biomarker or therapeutic target, paving the way for novel strategies in cancer treatment and other pathologies associated with dysregulation of its expression. In summary, the study of FAM135B recombinant protein is poised to contribute significantly to our understanding of its biological relevance and therapeutic potential, underscoring the importance of translating basic research into clinical applications.
